Internal Medicine, Clinical Cardiatric Electrophysiology · Naples, FL
NPI
1174516546
Since 2005
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
6609 Willow Park Dr Ste 100
Naples, FL, 34109
Phone (239) 643-9977
Groups this clinician bills Medicare through
Medicare paid, 2024
$930K
8,982 services
Medicare patients, 2024
1,175
Average age 80
Drug cost, 2024
$2.9M
5,057 prescriptions
Company payments, 2025
$809
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmet S Gursoy was code 93298 (external electrocardiographic monitoring), 1,800 times for 252 patients. In total Ahmet S Gursoy billed 8,982 services in 82 codes, and Medicare paid $930K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93298 External Electrocardiographic Monitoring | Office | 1,800 | 252 | $76.63 | $138K |
| 99213 Office E&M - Established | Office | 1,330 | 787 | $67.08 | $89K |
| 99214 Office E&M - Established | Office | 1,071 | 640 | $101.99 | $109K |
| 93280 External Electrocardiographic Monitoring | Office | 776 | 349 | $59.51 | $46K |
| 93000 Electrocardiogram | Office | 541 | 388 | $11.10 | $6,006 |
| 93291 External Electrocardiographic Monitoring | Office | 400 | 224 | $37.45 | $15K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 348 | 87 | $5.87 | $2,042 |
| 93306 Echocardiography (TTE/TEE) | Office | 329 | 321 | $150.72 | $50K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 200 | 100 | $367.67 | $74K |
| 93225 Electrocardiogram | Office | 149 | 142 | $12.04 | $1,794 |
| 93227 Electrocardiogram | Office | 148 | 141 | $12.99 | $1,923 |
| 93279 External Electrocardiographic Monitoring | Office | 117 | 53 | $50.81 | $5,945 |
| 93288 External Electrocardiographic Monitoring | Office | 110 | 65 | $45.53 | $5,008 |
| 93283 External Electrocardiographic Monitoring | Office | 108 | 53 | $73.99 | $7,991 |
| 93015 Electrocardiogram | Office | 101 | 101 | $52.16 | $5,268 |
By year: 2022 $1.1M for 12,698 services; 2023 $1.1M for 11,607 services; 2024 $930K for 8,982 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ahmet S Gursoy prescribed most often to Medicare patients was Amiodarone Hcl, with 548 prescriptions and refills. In total Ahmet S Gursoy wrote 5,057 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amiodarone Hcl Generic | 548 | 1,447 | 174 | $8,148 |
| Xarelto Rivaroxaban | 410 | 782 | 117 | $426K |
| Entresto Sacubitril/Valsartan | 329 | 721 | 84 | $453K |
| Eliquis Apixaban | 277 | 617 | 73 | $357K |
| Flecainide Acetate Generic | 261 | 704 | 81 | $14K |
| Metoprolol Succinate Generic | 234 | 676 | 76 | $4,114 |
| Propafenone Hcl Er Propafenone Hcl | 191 | 438 | 57 | $46K |
| Jardiance Empagliflozin | 184 | 388 | 46 | $218K |
| Amlodipine Besylate Generic | 173 | 493 | 58 | $1,496 |
| Losartan Potassium Generic | 152 | 407 | 45 | $1,293 |
| Carvedilol Generic | 137 | 379 | 40 | $1,115 |
| Furosemide Generic | 136 | 352 | 57 | $801 |
| Lisinopril Generic | 133 | 385 | 43 | $1,101 |
| Metoprolol Tartrate Generic | 131 | 350 | 50 | $934 |
| Atorvastatin Calcium Generic | 106 | 314 | 33 | $1,256 |
Brand drugs: 1,622 claims; generic drugs: 3,421 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmet S Gursoy $809 ($809 in general payments such as food, travel and fees) from 11 companies. The largest payer was Scpharmaceuticals Inc. with $248.
| Company | Payments | Amount |
|---|---|---|
| Scpharmaceuticals Inc. SCPH | 11 | $248 |
| Merck Sharp & Dohme LLC MRK | 5 | $129 |
| Amgen Inc. AMGN | 4 | $94.44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81.48 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $58.36 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $51.43 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $46.6 |
| Novo Nordisk Inc NVO | 2 | $32.99 |
| BridgeBio Pharma, Inc. BBIO | 1 | $30.51 |
| GlaxoSmithKline, LLC. GSK | 1 | $21.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.